| Identification of growth arrest and DNA-damage-inducible gene β (GADD45β) as a novel tumor suppressor in pituitary gonadotrope tumors KA Michaelis, AJ Knox, M Xu, K Kiseljak-Vassiliades, MG Edwards, ... Endocrinology 152 (10), 3603-3613, 2011 | 120 | 2011 |
| Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival M Xu, L Shorts-Cary, AJ Knox, B Kleinsmidt-DeMasters, K Lillehei, ... Endocrinology 150 (5), 2064-2071, 2009 | 73 | 2009 |
| Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity M Xu, AJ Knox, KA Michaelis, K Kiseljak-Vassiliades, ... Endocrinology 153 (7), 2963-2973, 2012 | 52 | 2012 |
| Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling H Madsen, TM Borges, AJ Knox, KA Michaelis, M Xu, KO Lillehei, ... The American journal of surgical pathology 35 (8), 1204-1213, 2011 | 48 | 2011 |
| Functional Consequences of AXL Sequence Variants in Hypogonadotropic Hypogonadism S Salian-Mehta, M Xu, AJ Knox, L Plummer, D Slavov, M Taylor, S Bevers, ... The Journal of Clinical Endocrinology & Metabolism 99 (4), 1452-1460, 2014 | 40 | 2014 |
| BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway AL Green, J DeSisto, P Flannery, R Lemma, A Knox, M Lemieux, ... Oncogene 39 (11), 2305-2327, 2020 | 36 | 2020 |
| Family with sequence similarity 5, member C (FAM5C) increases leukocyte adhesion molecules in vascular endothelial cells: implication in vascular inflammation J Sato, M Kinugasa, S Satomi-Kobayashi, K Hatakeyama, AJ Knox, ... PLoS One 9 (9), e107236, 2014 | 30 | 2014 |
| Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia W Xiong, AJ Knox, M Xu, K Kiseljak-Vassiliades, SP Colgan, KS Brodsky, ... Molecular Endocrinology 29 (3), 460-472, 2015 | 29 | 2015 |
| Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis AJ Knox, C Graham, J Bleskan, G Brodsky, D Patterson Gene 429 (1-2), 23-30, 2009 | 27 | 2009 |
| The production of transgenic mice expressing human cystathionine beta-synthase to study Down syndrome C Butler, AJ Knox, J Bowersox, S Forbes, D Patterson Behavior genetics 36, 429-438, 2006 | 27 | 2006 |
| Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine AL Green, P Flannery, TC Hankinson, B O’Neill, V Amani, J DeSisto, ... Neuro-Oncology Advances 2 (1), vdaa021, 2020 | 19 | 2020 |
| Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease AJ Knox, AL Scaling, MP Pinto, BS Bliesner, JM Haughian, ... Breast Cancer Research 16, 1-13, 2014 | 17 | 2014 |
| Novel RAF fusions in pediatric low-grade gliomas demonstrate MAPK pathway activation KT Lind, HV Chatwin, J DeSisto, P Coleman, B Sanford, AM Donson, ... Journal of Neuropathology & Experimental Neurology 80 (12), 1099-1107, 2021 | 7 | 2021 |
| The GART gene of purine biosynthesis: assessment of functional sites through mutagenesis in CHO cells and analysis of behavioral phenotypes in transgenic mice AJ Knox University of Colorado Denver, 2007 | 2 | 2007 |
| MODL-31. Novel in vivo models of post-radiation recurrent pediatric high-grade glioma show increased susceptibility to MAPK inhibition A Knox, J DeSisto, S Nelson-Taylor, P Coleman, B Van Court, A Donson, ... Neuro-Oncology 24 (Supplement_1), i176-i176, 2022 | 1 | 2022 |
| Abstract P2-04-05: Modeling luminal breast cancer heterogeneity: Combination therapies to suppress hormone receptor-negative subpopulations among receptor-positive ones AL Scaling, AJ Knox, MP Pinto, BS Bliesner, JM Haughian, ... Cancer Research 75 (9_Supplement), P2-04-05-P2-04-05, 2015 | 1 | 2015 |
| PRMT5 maintains tumor stem cells to promote pediatric high-grade glioma tumorigenesis J DeSisto, I Balakrishnan, A Knox, G Link, S Venkataraman, R Vibhakar, ... bioRxiv, 2024.03. 12.583794, 2024 | | 2024 |
| DIPG-57. TESTING FOR SYNERGY AMONG RADIATION AND HIGHLY CLINICALLY RELEVANT CHEMOTHERAPEUTIC AGENTS IN PATIENT-DERIVED MODELS OF DIFFUSE MIDLINE GLIOMA M Slade, G Link, J DeSisto, C Feddersen, D Bargas, A Knox, A Green Neuro-Oncology 25 (Suppl 1), i26, 2023 | | 2023 |
| A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease AJ Knox, B Van Court, A Oweida, E Barsh, J DeSisto, P Flannery, ... Frontiers in Oncology 13, 1105395, 2023 | | 2023 |
| DEVELOPMENT OF HUMANIZED IMMUNE SYSTEM, POSTERIOR FOSSA A EPENDYMOMA PATIENT-DERIVED XENOGRAFT MODEL A Griesinger, J Lang, A Donson, E Grimaldo, A Pierce, A Knox, J Steiner, ... NEURO-ONCOLOGY 24, 174-174, 2022 | | 2022 |
Kevin LilleheiUniversity of ColoradoEmail verificata su ucdenver.edu
